4D Molecular Corp (FDMT): Forvard P/S multiplikatori

4D Molecular Therapeutics Inc (FDMT) grafik logotipi

4D Molecular Therapeutics (FDMT) kompaniyasining o'sishi AI va robototexnika yordamida gen dori vositalari sintezini avtomatlashtirishga asoslangan. Oldingi sotuvlar nisbatidagi narx ko'rsatkichi (forward price-to-sales) ushbu tendentsiyani tasdiqlaydi, bunda 7.20 ushbu metrikaning joriy qiymatini ko'rsatadi. Narxlar dinamikasi kistik fibroz va makulyar degeneratsiyani davolash sinovlari bilan boshqarilmoqda. Shu bilan birga, tor texnologik bazaning xavflari ishlanmalarni pulmonologiya va oftalmologiya o'rtasida taqsimlash orqali yumshatiladi.

4D Molecular Therapeutics, Inc. (FDMT): Forvard narx/daromad multiplikatori 04.07.2022dan 16.11.2026gacha

4dmoleculartherapeutics.com (FDMT) kompaniyasi koʻrsatkichlari kesimi va tahlili

- bozor narxi va tahlilchilarning maqsadli narxlari:
Kompaniyaning fundamental tahlili:4D Molecular Therapeutics Inc - FDMT
4D Molecular Therapeutics brend mahsuloti

Kundalik forward P/S ko'rsatkichi kelajakdagi daromad oqimlariga oid bozor kutganlarini o'lchaydi va joriy biznes qiymatini uning kengayish sur'atlari bilan solishtirish imkonini beradi. Kardiologiya va oftalmologiya sohalarida innovatsion AAV platformalarini ishlab chiqayotgan 4D Molecular Therapeutics (FDMT) uchun forward bozor kapitalizatsiyasining daromadga nisbatini tahlil qilish, rahbariyatning ilmiy tajribasi uchun qo'llanilgan premium asosli ekanligini tasdiqlaydi va biotexnologiya risklari sharoitida kapital barqarorligining ob'ektiv bahosini taqdim etadi.

4D Molecular Therapeutics kimlar bilan raqobatlashadi

Forvard P/S multiplikatori TEM (Tempus Labs)|Qiagen N.V. - Narxning prognoz qilingan daromadga nisbati|IONS - Narxning prognoz qilingan daromadga nisbati|Bozor kapitallashuvining kelajakdagi daromadga nisbati repligen.com|RNA: Forvard P/S multiplikatori|CRISPR Therapeutics Inc (CRSP) - Forvard P/S multiplikatori|WGS (GeneDx Holdings) - Forvard P/S multiplikatori|RARE: Sotuvga nisbatan forvard narx|Forvard narx/daromad multiplikatori BEAM (Beam Therapeutics Corp)|SRPT: Kelajakdagi narxning daromadga nisbati|Forvard P/S multiplikatori TWST (Twist Bioscience Inc)|Kapitalizatsiyaning kutilayotgan sotuvga nisbati 10x Genomics Corp (TXG)|intelliatx.com - Forvard P/S multiplikatori|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Stoke STOK|biolifesolutions.com (BLFS) - Narxning prognoz qilingan daromadga nisbati|WVE - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Forvard narx/daromad multiplikatori MAZE|Forvard narx/daromad multiplikatori Sionna Therapeutics, Inc. (SION)|Forvard narx/daromad multiplikatori PRME (Prime Medicine Bio)|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Taysha|uniQure Pharma - Forvard narx/daromad multiplikatori|MeiraGTx Holdings plc - Narxning prognoz qilingan daromadga nisbati|regenxbio.com - Forvard P/S multiplikatori|Solid Bio (SLDB) - Forvard narx/daromad multiplikatori|OCGN: Forvard P/S multiplikatori|Forvard narx/daromad multiplikatori Pacific Biosciences of California|BNTC (Benitec Biopharma Inc.) - Forvard P/S multiplikatori|Kapitalizatsiyaning prognoz qilingan daromadga nisbati DSGN (Design Therapeutics)|Forvard P/S multiplikatori RCKT|Lexeo Therapeutics, Inc. - Kapitalizatsiyaning prognoz qilingan daromadga nisbati|Narxning prognoz qilingan daromadga nisbati Korro Bio, Inc. KRRO|EDIT: Kapitalizatsiyaning prognoz qilingan daromadga nisbati|SLN - Narxning prognoz qilingan daromadga nisbati|Prognoz narxning daromadga nisbati ProQR Therapeutics (PRQR)|CDXS (Codexis Bio) - Forvard narx/daromad multiplikatori|Sangamo Therapeutics Inc. (SGMO) - Forvard P/S multiplikatori|Narxning prognoz qilingan daromadga nisbati Nautilus Bio|Bozor kapitallashuvining kelajakdagi daromadga nisbati Metagenomi Therapeutics MGX|Narxning prognoz qilingan daromadga nisbati Precision BioSciences (DTIL)|GBIO - Bozor kapitallashuvining kelajakdagi daromadga nisbati|Forvard P/S multiplikatori BOLD (Boundless Bio, Inc)|XCUR - Forvard narx/daromad multiplikatori|IMNN - Narxning prognoz qilingan daromadga nisbati|Bozor kapitallashuvining kelajakdagi daromadga nisbati Phio Pharmaceuticals Corp|MBIO: Forvard P/S multiplikatori|TransCode (RNAZ) - Forvard P/S multiplikatori|BNGO (Bionano) - Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati Applied DNA Sciences, Inc. APDN|Forvard P/S multiplikatori BLUE|ImmunoPrecise Antibodies Ltd - Kapitalizatsiyaning prognoz qilingan daromadga nisbati|Narxning prognoz qilingan daromadga nisbati Omega Therapeutics OMGA|OMIC: Kapitalizatsiyaning prognoz qilingan daromadga nisbati|RGLS: Forvard narx/daromad multiplikatori|Sotuvga nisbatan forvard narx SYRS (Syros Pharmaceuticals, Inc.)|Telesis Bio, Inc. (TBIO) - Narxning prognoz qilingan daromadga nisbati|Kelajakdagi narxning daromadga nisbati TCON (TRACON)|Narxning prognoz qilingan daromadga nisbati Unity Biotechnology, Inc.